WWW.WSJ.COM
WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million
WuXi Biologics move to sell the facility could strengthen the companys cash flow and margins as it navigates global uncertainties.
0 Commentaires 0 Parts 56 Vue